Baidu
map

Efficacy and safety of SGLT-2i in overweight/obese, non-diabetic individuals: a meta-analysis of randomized controlled trials

Shi, YT; Si, YX; Fu, RR; Zhang, MT; Jiang, K; Dai, W; Shen, JY; Li, XY; Yuan, Y

Yuan, Y (通讯作者),Univ Chinese Acad Sci, HwaMei Hosp, Dept Gen Surg, Northwest St 41, Ningbo 315010, Zhejiang, Peoples R China.

ENDOKRYNOLOGIA POLSKA, 2022; 73 (1): 71

Abstract

Introduction: Sodium-glucose cotransporter 2 inhibitor (SGLT-2i) has been shown to decrease blood glucose levels in type 2 diabetes mellitus (T2DM) pa......

Full Text Link


Baidu
map
Baidu
map
Baidu
map